| Literature DB >> 25857231 |
Jun Matsumoto1, Noritaka Ariyoshi2, Masahiro Sakakibara3, Takeo Nakanishi4, Yoshiyuki Okubo3, Nobumitsu Shiina3, Kaoru Fujisaki3, Takeshi Nagashima3, Yukio Nakatani5, Ikumi Tamai4, Harumi Yamada6, Hiroshi Takeda6, Itsuko Ishii7.
Abstract
Estrone-3-sulfate (E1S) is thought to be a major estrogen precursor in estrogen receptor (ER)-positive breast cancer. Since E1S is a hydrophilic compound, the uptake of E1S into cancer cells is probably mediated by transporters, such as organic anion-transporting polypeptide (OATP, SLCO) family. In this study, we investigated the relationship between expression of OATP2B1 and cell proliferation in ER-positive breast cancer. Cell-based assays were carried out in MCF-7 cells both with and without overexpression of OATP2B1. Normal breast and tumor tissues were collected and used in this study. Cell proliferation, ER-mediated transcriptional activities and estradiol secretion were stimulated by addition of E1S to the culture medium of MCF-7 cells. These stimulatory effects were significantly greater in MCF-7 cells overexpressing OATP2B1 than in control cells. The expression level of SLCO2B1 mRNA was significantly correlated with histological grade, Ki-67 labelling index and mRNA expression of steroid sulfatase. The expression level of SLCO2B1 mRNA in luminal B-like cancers was higher than that in luminal A-like cancers. Uptake of E1S resulted in down-regulation of ERα protein and induction of Ki-67 in MCF-7 cells. The present study suggests that OATP2B1 is involved in cell proliferation by increasing the amount of estrogen in ER-positive breast cancer cells.Entities:
Keywords: Breast cancer; Estrogen receptor; Estrone-3-sulfate; Ki-67; Luminal A-like; Luminal B-Like; Organic anion-transporting polypeptide 2B1
Mesh:
Substances:
Year: 2014 PMID: 25857231 DOI: 10.1016/j.dmpk.2014.10.005
Source DB: PubMed Journal: Drug Metab Pharmacokinet ISSN: 1347-4367 Impact factor: 3.614